Literature DB >> 35838949

Multivalent Vaccine Strategies in Battling the Emergence of COVID-19 Variants.

Paul C Guest1.   

Abstract

The emergence of new SARS-CoV-2 variants has led to increased transmission and more severe cases of COVID-19, with some having the ability to escape the existing vaccines. This review discusses the importance of developing new vaccine strategies to keep pace with these variants to more effectively manage the pandemic. Many of the new vaccine approaches include multivalent display of the most highly mutated regions in the SARS-CoV-2 spike protein such that they resemble a virus particle and can stimulate an effective neutralization response. It is hoped that such approaches help to manage the existing pandemic and provide a robust infrastructure toward fast tracking responses across the world in case of future pandemics.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibody; COVID-19; Multivalent; Pandemic; SARS-CoV-2; Vaccine; Variant

Mesh:

Substances:

Year:  2022        PMID: 35838949     DOI: 10.1007/978-1-0716-2395-4_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Delta variant: What is happening with transmission, hospital admissions, and restrictions?

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2021-06-15

Review 2.  Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.

Authors:  M Wahid; A Jawed; R K Mandal; H G Dailah; E M Janahi; K Dhama; P Somvanshi; S Haque
Journal:  Eur Rev Med Pharmacol Sci       Date:  2021-09       Impact factor: 3.507

3.  India grapples with second wave of COVID-19.

Authors:  Udani Samarasekera
Journal:  Lancet Microbe       Date:  2021-06-02

Review 4.  Status Report on COVID-19 Vaccines Development.

Authors:  Arun Kumar; William E Dowling; Raúl Gómez Román; Amol Chaudhari; Celine Gurry; Tung Thanh Le; Stig Tollefson; Carolyn E Clark; Valentina Bernasconi; Paul A Kristiansen
Journal:  Curr Infect Dis Rep       Date:  2021-04-14       Impact factor: 3.725

Review 5.  Novel SARS-CoV-2 variants: the pandemics within the pandemic.

Authors:  Erik Boehm; Ilona Kronig; Richard A Neher; Isabella Eckerle; Pauline Vetter; Laurent Kaiser
Journal:  Clin Microbiol Infect       Date:  2021-05-17       Impact factor: 8.067

6.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Authors:  Sam Abbott; Rosanna C Barnard; Christopher I Jarvis; Adam J Kucharski; James D Munday; Carl A B Pearson; Timothy W Russell; Damien C Tully; Alex D Washburne; Tom Wenseleers; Nicholas G Davies; Amy Gimma; William Waites; Kerry L M Wong; Kevin van Zandvoort; Justin D Silverman; Karla Diaz-Ordaz; Ruth Keogh; Rosalind M Eggo; Sebastian Funk; Mark Jit; Katherine E Atkins; W John Edmunds
Journal:  Science       Date:  2021-03-03       Impact factor: 63.714

7.  Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.

Authors:  Robert Challen; Ellen Brooks-Pollock; Jonathan M Read; Louise Dyson; Krasimira Tsaneva-Atanasova; Leon Danon
Journal:  BMJ       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.